We are live on ! Find out more
FOLD

Amicus Therapeutics
FOLD

Delisted

FOLD was delisted on the 24th of April, 2026.

Back to rankings

60 hedge funds and large institutions have $136M invested in Amicus Therapeutics in 2014 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 16 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

91% more capital invested

Capital invested by funds: $71M → $136M (+$64.8M)

10% more call options, than puts

Call options by funds: $557K | Put options by funds: $505K

6% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 16

12% less funds holding

Funds holding: 68 → 60 (-8)

35% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 23

Holders
60
Holders Change
-8
Holders Change %
-11.76%
% of All Funds
1.72%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
15
Increased
17
Reduced
16
Closed
23
Calls
$557K
Puts
$505K
Net Calls
+$52K
Net Calls Change
-$50K

Top Buyers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
+$26.7M
2
GTC
Ghost Tree Capital
New York
+$1.41M
3
Jane Street
Jane Street
New York
+$1.05M
4
Marshall Wace
Marshall Wace
United Kingdom
+$797K
5
Millennium Management
Millennium Management
New York
+$737K

Top Sellers

Rank Fund Capital Flow
1
RIM
RS Investment Management
California
-$5.83M
2
UBS AM
UBS AM
Illinois
-$2.54M
3
RG
Redmile Group
California
-$1.99M
4
BFA
BlackRock Fund Advisors
California
-$1.8M
5
State Street
State Street
Massachusetts
-$947K
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
26
Bridgeway Capital Management
Texas
$405K – – –
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$388K – – –
SM
28
Sabby Management
Florida
$334K +$235K +100,000 New
Bank of America
29
Bank of America
North Carolina
$333K +$229K +97,412 +4,701%
Group One Trading
30
Group One Trading
Illinois
$303K +$175K +74,754 +472%
BFA
31
BlackRock Fund Advisors
California
$299K -$1.8M -764,978 -90%
COPPSERS
32
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$291K +$204K +87,016 New
Two Sigma Investments
33
Two Sigma Investments
New York
$248K +$54.1K +23,037 +45%
SFM
34
Soros Fund Management
New York
$235K +$165K +70,500 New
Jacobs Levy Equity Management
35
Jacobs Levy Equity Management
New Jersey
$222K +$156K +66,400 New
LP
36
LMR Partners
United Kingdom
$220K +$154K +65,805 New
Goldman Sachs
37
Goldman Sachs
New York
$210K +$43.9K +18,692 +42%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$190K -$218K -92,828 -62%
PRHC
39
P.R. Herzig & Co
New York
$177K – – –
SIP
40
Stoneridge Investment Partners
Pennsylvania
$161K +$55.5K +23,625 +97%
CS
41
Credit Suisse
Switzerland
$134K -$92.7K -39,507 -50%
Barclays
42
Barclays
United Kingdom
$130K +$98.6K +42,019 +3,200%
HCM
43
Highbridge Capital Management
New York
$109K +$76.3K +32,508 New
Brown Advisory
44
Brown Advisory
Maryland
$106K – – –
AL
45
Airain Ltd
Guernsey
$101K +$70.8K +30,166 New
State Street
46
State Street
Massachusetts
$97K -$947K -403,608 -93%
DCC
47
Dow Chemical Company
Michigan
$74K – – –
U
48
UBS
Switzerland
$57K +$4.7K +2,000 +13%
GC
49
Guggenheim Capital
Illinois
$56K -$17.3K -7,370 -31%
NSEDCP
50
NJ State Employees Deferred Compensation Plan
New Jersey
$50K – – –
1
2
3 4

FOLD Hedge Fund Activity: Q2 2014 in Review

60 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q2 2014, worth a combined $136M — up 91% from $71M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of FOLD and 15 opened new positions — a net loss of 8 holders — while 16 trimmed existing stakes and 17 added.

The largest buyer was Perceptive Advisors, adding an estimated $26.7M. The largest seller was RS Investment Management, exiting entirely with an estimated $5.83M sold.

  • 60 institutional investors held Amicus Therapeutics (FOLD) as of Q2 2014, down from 68 in Q1 2014.
  • Funds reported $136M of Amicus Therapeutics stock for Q2 2014, up 91% quarter-over-quarter.
  • 15 funds opened new Amicus Therapeutics positions in Q2 2014 and 23 closed out, a net change of -8 holders.
  • The largest Amicus Therapeutics buyer in Q2 2014 was Perceptive Advisors, an estimated $26.7M added.
  • The largest Amicus Therapeutics seller in Q2 2014 was RS Investment Management, an estimated $5.83M sold.

Based on aggregated 13F filings for Q2 2014.